ホーム 計算ツール
代理店ログイン

Thrombopoietin Receptor

The thrombopoietin receptor also known as the myeloproliferative leukemia protein or CD110 (Cluster of Differentiation 110) is a protein that in humans is encoded by the MPL (myeloproliferative leukemia virus) oncogene.
Cat. No. 製品名 CAS No. Purity Chemical Structure
T7417 Avatrombopag 570406-98-3 98%
Avatrombopag is a new oral thrombopoietin (TPO) receptor agonist, activating TPO receptor and increasing megakaryocytic proliferation/differentiation and platele...
T67894 Butyzamide 1110767-45-7 98%
Butyzamide is an effective and oral Mpl activator. It is a novel non-peptide-based molecule with antagonistic effects on thrombopoietin (TPO) receptors, which pr...
T3882 4”-O-Glucosylvitexin 76135-82-5 98%
Glucosylvitexin inhibits TPO activity.
TQ0223 Lusutrombopag 1110766-97-6 98%
Lusutrombopag is an orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist for chronic liver disease (CLD) patients with thrombocytopenia prio...
Avatrombopag
T7417
Avatrombopag is a new oral thrombopoietin (TPO) receptor agonist, activating TPO receptor and increasing megakaryocytic proliferation/differentiation and platele...
Butyzamide
T67894
Butyzamide is an effective and oral Mpl activator. It is a novel non-peptide-based molecule with antagonistic effects on thrombopoietin (TPO) receptors, which pr...
4”-O-Glucosylvitexin
T3882
Glucosylvitexin inhibits TPO activity.
Lusutrombopag
TQ0223
Lusutrombopag is an orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist for chronic liver disease (CLD) patients with thrombocytopenia prio...